The INNOTEST PHOSPHO-TAU(181P) is a solid-phase enzyme immunoassay for the quantitative determination of phosphorylated Tau (Phospho-Tau(181P)) in human cerebrospinal fluid (CSF).
The combined use of CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression.1-5
The discrimination of AD from non-AD types of dementia such as dementia with Lewy Bodies may be further improved using the quantification of CSF-phospho-Tau(181). 6-7
Advantages of our assays
- Simple colorimetric immunoassays that are easily automated on microplate-processor
- Supported by many peer-reviewed scientific publications
- Less than 300 μL of CSF necessary for determination of complete biomarker profile
- Assay range consistent with biological range of values